L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP

Conditions:   Severe Obesity;   Type 2 Diabetes Mellitus in Obese Intervention:   Other: Analyze basal expression incretin for immunolabeling and mRNA expression glucagon-like secretion peptide-1 (GLP-1) and peptide YY (PYY 3-36) incretins by L cells. Sponsor:   University of Sao Paulo General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials